244 related articles for article (PubMed ID: 33766793)
61. Pediatricians' Attitudes and Beliefs about Long-Acting Reversible Contraceptives Influence Counseling.
Berlan ED; Pritt NM; Norris AH
J Pediatr Adolesc Gynecol; 2017 Feb; 30(1):47-52. PubMed ID: 27639750
[TBL] [Abstract][Full Text] [Related]
62. Long-acting reversible contraception knowledge, attitudes and use among HIV-infected and -uninfected women and their providers.
Teodoro N; Fu A; Ohly NT; Shalev N; Matseoane-Peterssen D; Westhoff CL
Contraception; 2019 Oct; 100(4):269-274. PubMed ID: 31226320
[TBL] [Abstract][Full Text] [Related]
63. Cost Sharing and Utilization of Postpartum Intrauterine Devices and Contraceptive Implants Among Commercially Insured Women.
Moniz MH; Soliman AB; Kolenic GE; Tilea A; Fendrick AM; Bell S; Dalton VK
Womens Health Issues; 2019; 29(6):465-470. PubMed ID: 31495642
[TBL] [Abstract][Full Text] [Related]
64. Role of social network in decision making for increasing uptake and continuing use of long acting reversible (LARC) methods in Pakistan.
Sarfraz M; Hamid S; Rawstorne P; Ali M; Jayasuriya R
Reprod Health; 2021 May; 18(1):96. PubMed ID: 34001169
[TBL] [Abstract][Full Text] [Related]
65. MyLARC: A Theory-Based Interactive Smartphone App to Support Adolescents' Use of Long-Acting Reversible Contraception.
Timmons SE; Shakibnia EB; Gold MA; Garbers S
J Pediatr Adolesc Gynecol; 2018 Jun; 31(3):285-290. PubMed ID: 29162531
[TBL] [Abstract][Full Text] [Related]
66. Mental health diagnoses and early removal of long-acting reversible contraception.
Bello JK; Salas J; Meyer D; Heiden-Rootes K; Davis DM; Keegan Garrett E; White MM; Schmeidler P
J Affect Disord; 2020 Feb; 262():333-336. PubMed ID: 31740110
[TBL] [Abstract][Full Text] [Related]
67. [Long-acting reversible contraception methods in women under 26 years of age].
Frutos-Balibrea I; Sánchez-Núñez MI; Pedrero-Pérez EJ; Haro-León A; Benítez-Robredo MT
Semergen; 2021 Oct; 47(7):457-464. PubMed ID: 34148782
[TBL] [Abstract][Full Text] [Related]
68. Cross-sectional assessment of government health center needs to implement long-acting reversible contraception services in rural Rwanda.
Mazzei A; Ingabire R; Karita E; Mukamuyango J; Nyombayire J; Parker R; Tichacek A; Allen S; Wall KM
BMC Womens Health; 2021 Dec; 21(1):411. PubMed ID: 34911535
[TBL] [Abstract][Full Text] [Related]
69. "I was just concerned about getting pregnant": Attitudes toward pregnancy and contraceptive use among adolescent girls and young women in Thika, Kenya.
Daniel AK; Casmir E; Oluoch L; Micheni M; Kiptinness C; Wald A; Mugo NR; Roxby AC; Ngure K
BMC Pregnancy Childbirth; 2023 Jul; 23(1):493. PubMed ID: 37403049
[TBL] [Abstract][Full Text] [Related]
70. Strengthening Youth Friendly Health Services through Expanding Method Choice to include Long-Acting Reversible Contraceptives for Ethiopian Youth.
Fikree FF; Abshiro WK; Mai MM; Hagos KL; Asnake M
Afr J Reprod Health; 2017 Sep; 21(3):37-48. PubMed ID: 29624927
[TBL] [Abstract][Full Text] [Related]
71. An initiative to implement immediate postpartum long-acting reversible contraception in rural New Mexico.
Palm HC; Degnan JH; Biefeld SD; Reese AL; Espey E; Hofler LG
Am J Obstet Gynecol; 2020 Apr; 222(4S):S911.e1-S911.e7. PubMed ID: 31978431
[TBL] [Abstract][Full Text] [Related]
72. Factors influencing the provision of long-acting reversible contraception in California.
Biggs MA; Harper CC; Malvin J; Brindis CD
Obstet Gynecol; 2014 Mar; 123(3):593-602. PubMed ID: 24499746
[TBL] [Abstract][Full Text] [Related]
73. Final Program Data and Factors Associated With Long-Acting Reversible Contraception Removal: The Zika Contraception Access Network.
Lathrop E; Hurst S; Mendoza Z; Zapata LB; Cordero P; Powell R; Green C; Moreno N; Jamieson DJ; Romero L
Obstet Gynecol; 2020 May; 135(5):1095-1103. PubMed ID: 32282596
[TBL] [Abstract][Full Text] [Related]
74. Provider and Health System Factors Associated with Usage of Long-Acting Reversible Contraception in Adolescents.
Smith AJB; Harney KF; Singh T; Hurwitz AG
J Pediatr Adolesc Gynecol; 2017 Dec; 30(6):609-614. PubMed ID: 28502827
[TBL] [Abstract][Full Text] [Related]
75. Postabortion contraception: qualitative interviews on counseling and provision of long-acting reversible contraceptive methods.
Morse J; Freedman L; Speidel JJ; Thompson KM; Stratton L; Harper CC
Perspect Sex Reprod Health; 2012 Jun; 44(2):100-6. PubMed ID: 22681425
[TBL] [Abstract][Full Text] [Related]
76. A qualitative analysis of long-acting reversible contraception.
Sundstrom B; Baker-Whitcomb A; DeMaria AL
Matern Child Health J; 2015 Jul; 19(7):1507-14. PubMed ID: 25424456
[TBL] [Abstract][Full Text] [Related]
77. Accessibility of long-acting reversible contraceptives (LARCs) in Federally Qualified Health Centers (FQHCs).
Beeson T; Wood S; Bruen B; Goldberg DG; Mead H; Rosenbaum S
Contraception; 2014 Feb; 89(2):91-6. PubMed ID: 24210278
[TBL] [Abstract][Full Text] [Related]
78. The Impact of an Adolescent Gynecology Provider on Intrauterine Device and Subdermal Contraceptive Implant Use Among Adolescent Patients.
Crain CL; DeFruscio AE; Shah PT; Hunt L; Yoost JL
J Pediatr Adolesc Gynecol; 2020 Aug; 33(4):377-381. PubMed ID: 32087404
[TBL] [Abstract][Full Text] [Related]
79. Addressing Administrative and System-Level Challenges to Implementation of Long-Acting Reversible Contraceptives in Adolescent Medicine and Pediatric and Adolescent Gynecology Practices: A Qualitative Study.
Lunde B; Kaznoch D; Mahoney N; Akers AY; Rome ES
J Pediatr Adolesc Gynecol; 2023 Jun; 36(3):304-310. PubMed ID: 36758719
[TBL] [Abstract][Full Text] [Related]
80. Contraceptive method switching among women living in sub-Saharan Africa participating in an HIV-1 prevention trial: a prospective cohort study.
Chappell CA; Harkoo I; Szydlo DW; Bunge KE; Singh D; Nakabiito C; Mhlanga F; Kamira B; Piper JM; Balkus JE; Hillier SL;
Contraception; 2019 Sep; 100(3):214-218. PubMed ID: 31226323
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
